Introduction to Focus on Fabry nephropathy: biomarkers, progression, and disease severity.
Warnock
David G
DG
Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Room 614 ZRB UAB, Birmingham, Alabama 35294-0007, USA. dwarnock@uab.edu
Remuzzi
Giuseppe
G
Brenner
Barry M
BM
Levin
Adeera
A
Wanner
Christoph
C
D015415:Biomarkers / Q000378:metabolism; D018450:Disease Progression; D000795:Fabry Disease / Q000150:complications* / Q000175:diagnosis / Q000378:metabolism / Q000628:therapy; D006801:Humans; D007674:Kidney Diseases / Q000175:diagnosis / Q000209:etiology* / Q000378:metabolism / Q000628:therapy; D012720:Severity of Illness Index
D015415:Biomarkers